Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Otolaryngology | 2 | 2023 | 24 | 1.530 |
Why?
|
| Nose Neoplasms | 2 | 2017 | 17 | 1.100 |
Why?
|
| Mouth Neoplasms | 2 | 2025 | 32 | 1.040 |
Why?
|
| Head and Neck Neoplasms | 2 | 2024 | 153 | 0.780 |
Why?
|
| Skull Base | 1 | 2021 | 13 | 0.740 |
Why?
|
| Neck | 1 | 2020 | 46 | 0.700 |
Why?
|
| Head | 1 | 2020 | 52 | 0.690 |
Why?
|
| Preoperative Care | 1 | 2021 | 177 | 0.680 |
Why?
|
| Robotic Surgical Procedures | 1 | 2020 | 112 | 0.600 |
Why?
|
| Software | 1 | 2021 | 374 | 0.580 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2017 | 15 | 0.580 |
Why?
|
| Esthesioneuroblastoma, Olfactory | 1 | 2017 | 2 | 0.580 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 639 | 0.570 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 460 | 0.520 |
Why?
|
| Algorithms | 1 | 2021 | 1002 | 0.500 |
Why?
|
| Internship and Residency | 1 | 2023 | 747 | 0.490 |
Why?
|
| Melanoma | 1 | 2016 | 335 | 0.410 |
Why?
|
| Paranasal Sinuses | 2 | 2021 | 7 | 0.360 |
Why?
|
| Endoscopy | 2 | 2021 | 104 | 0.320 |
Why?
|
| Sinusitis | 2 | 2019 | 27 | 0.300 |
Why?
|
| Humans | 17 | 2025 | 60132 | 0.250 |
Why?
|
| Margins of Excision | 1 | 2025 | 24 | 0.240 |
Why?
|
| Male | 12 | 2025 | 27971 | 0.240 |
Why?
|
| Free Tissue Flaps | 1 | 2024 | 2 | 0.230 |
Why?
|
| Osteoradionecrosis | 1 | 2024 | 3 | 0.230 |
Why?
|
| Female | 12 | 2025 | 31250 | 0.220 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2025 | 239 | 0.200 |
Why?
|
| Salvage Therapy | 1 | 2022 | 74 | 0.200 |
Why?
|
| Adolescent | 4 | 2021 | 5958 | 0.190 |
Why?
|
| Databases, Factual | 3 | 2025 | 849 | 0.180 |
Why?
|
| Survival Rate | 3 | 2018 | 793 | 0.180 |
Why?
|
| Adult | 8 | 2025 | 15985 | 0.180 |
Why?
|
| Middle Aged | 9 | 2025 | 16535 | 0.180 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 302 | 0.180 |
Why?
|
| Neurosurgical Procedures | 1 | 2021 | 94 | 0.170 |
Why?
|
| Printing, Three-Dimensional | 1 | 2020 | 31 | 0.170 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2018 | 61 | 0.170 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 319 | 0.170 |
Why?
|
| Robotics | 1 | 2020 | 54 | 0.170 |
Why?
|
| Aged | 7 | 2025 | 13581 | 0.170 |
Why?
|
| Young Adult | 2 | 2021 | 4396 | 0.160 |
Why?
|
| Nasal Polyps | 1 | 2019 | 9 | 0.160 |
Why?
|
| Treatment Outcome | 6 | 2024 | 5262 | 0.160 |
Why?
|
| Retrospective Studies | 5 | 2024 | 6139 | 0.160 |
Why?
|
| Doxycycline | 1 | 2019 | 41 | 0.160 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 5197 | 0.160 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 2505 | 0.150 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2017 | 3 | 0.150 |
Why?
|
| Intracranial Pressure | 1 | 2017 | 20 | 0.150 |
Why?
|
| Tampons, Surgical | 1 | 2017 | 1 | 0.150 |
Why?
|
| Nasal Cavity | 1 | 2017 | 10 | 0.150 |
Why?
|
| Meningeal Neoplasms | 1 | 2018 | 57 | 0.140 |
Why?
|
| Meningioma | 1 | 2018 | 58 | 0.140 |
Why?
|
| Rhinitis | 1 | 2017 | 22 | 0.140 |
Why?
|
| Pharynx | 1 | 2017 | 21 | 0.140 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2017 | 5 | 0.140 |
Why?
|
| Rhabdomyosarcoma | 1 | 2017 | 17 | 0.140 |
Why?
|
| Ambulatory Care Facilities | 1 | 2017 | 103 | 0.140 |
Why?
|
| Maxillary Sinus Neoplasms | 1 | 2016 | 2 | 0.140 |
Why?
|
| United States | 4 | 2025 | 7622 | 0.130 |
Why?
|
| Carcinoma | 1 | 2016 | 117 | 0.130 |
Why?
|
| Postoperative Complications | 2 | 2024 | 1172 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2016 | 558 | 0.120 |
Why?
|
| Thrombopoiesis | 1 | 2014 | 1 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2017 | 409 | 0.110 |
Why?
|
| Erythropoiesis | 1 | 2014 | 35 | 0.110 |
Why?
|
| Prognosis | 1 | 2017 | 1591 | 0.100 |
Why?
|
| RNA, Long Noncoding | 1 | 2014 | 152 | 0.100 |
Why?
|
| Child | 1 | 2020 | 4336 | 0.090 |
Why?
|
| Obesity | 1 | 2017 | 1192 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 1039 | 0.080 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 361 | 0.070 |
Why?
|
| Chronic Disease | 2 | 2019 | 745 | 0.060 |
Why?
|
| Microsurgery | 1 | 2024 | 52 | 0.060 |
Why?
|
| Sex Factors | 1 | 2025 | 969 | 0.050 |
Why?
|
| Cadaver | 1 | 2021 | 104 | 0.050 |
Why?
|
| Incidence | 1 | 2025 | 1265 | 0.050 |
Why?
|
| Healthcare Disparities | 1 | 2025 | 332 | 0.050 |
Why?
|
| Methylprednisolone | 1 | 2019 | 31 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2019 | 345 | 0.040 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2017 | 15 | 0.040 |
Why?
|
| Hospitals, Urban | 1 | 2017 | 44 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 435 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2019 | 680 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 391 | 0.030 |
Why?
|
| Nausea | 1 | 2017 | 109 | 0.030 |
Why?
|
| Chemoradiotherapy | 1 | 2016 | 50 | 0.030 |
Why?
|
| Pain, Postoperative | 1 | 2017 | 133 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 792 | 0.030 |
Why?
|
| Megakaryocyte-Erythroid Progenitor Cells | 1 | 2014 | 1 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 1481 | 0.030 |
Why?
|
| Erythroblasts | 1 | 2014 | 15 | 0.030 |
Why?
|
| Megakaryocytes | 1 | 2014 | 18 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1471 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2014 | 172 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 100 | 0.030 |
Why?
|
| Species Specificity | 1 | 2014 | 335 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2017 | 428 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2014 | 250 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 661 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 592 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 3218 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2014 | 1459 | 0.020 |
Why?
|
| Mice | 1 | 2014 | 10343 | 0.010 |
Why?
|
| Animals | 1 | 2014 | 19768 | 0.010 |
Why?
|